Bio-Techne Corp. diskutieren
Bio-Techne Corp.
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Aktie / Ausrüstung & Versorgung / Mid Cap /
57,00 €
-0,88 %
Bio-Techne Corp (NASDAQ: TECH) is now covered by analysts at TD Cowen. They set a "buy" rating and a $65.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Corp (NASDAQ: TECH) is now covered by analysts at Stephens. They set an "overweight" rating and a $65.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $55.00.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Evercore ISI from $60.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at TD Cowen from $65.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $59.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at UBS Group AG from $65.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Argus from $65.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) was given a new $72.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Vertex Pharmaceuticals Inc. diskutieren